Interferon beta, a cofactor in the interferon gamma production induced by gram-negative bacteria in mice by unknown
Interferon/3,  a Cofactor in the Interferon 3' 
Production Induced by Gram-negative  Bacteria in 
Mice 
By Yasunory  Yaegashi,  Peter  Nielsen,  Andreas  Sing,  Chris  Galanos, 
and Marina  A.  Freudenberg 
From the Max-Planck-lnstitut fiir Immunbiologie, D-79108 Freibur~ Germany 
Summary 
The interferon (IFN) 3' production of splenocytes from closely related C57BL/lOScSn  (Sn) and 
C57BL/10ScCr (Cr) mice was compared. Concanavalin A and CD3 monoclonal antibodies induced 
high levels of IFN-'y in both Sn and Cr splenocytes. By contrast, treatment with gram-negative 
bacteria induced IFN-'y only in Sn splenocytes; in Cr splenocytes, the IFN-), response was heavily 
impaired. The IFN-3, induction by bacteria requires the cooperation of IFN-3,-producing cells 
with macrophages. Depletion of macrophages from Sn splenocytes resulted in the loss of ability 
to produce IFN-3~ after bacterial stimulation. Reconstitution with new Sn macrophages restored 
the IFN-'y responsiveness, whereas reconstitution with Cr macrophages failed to do so. Normal 
function of IFN-3,-producing cells and a defective function of macrophages of Cr mice was 
demonstrated by evidence showing that whole or macrophage-depleted Cr splenocytes, when 
supplemented with Sn macrophages, acquire the ability to produce IFN-3, in response to bacteria. 
A similar effect was achieved by supplementing Cr splenocytes with supernatants of bacteria- 
stimulated Sn macrophages or with recombinant murine IFN-fl or IFN-ot. Preincubation of 
active macrophage supernatants with antibodies to IFN-/~ suppressed the helper activity for Cr 
splenocytes.  Moreover,  the bacteria-induced production of IFN-3' by Sn splenocytes could be 
inhibited by antibodies to murine IFN-3. The results provide evidence that IFN-3 is an important 
cofactor of IFN-'y induction, which is not induced in Cr mice by gram-negative bacteria. 
C 
57BL/10ScCr  (Cr) 1 mice,  in  contrast  to  the closely 
related  C57BL/10ScSn (Sn) mice, are highly resistant 
to all LPS effects (1-4). Coutinho and Meo (1) presented evi- 
dence that Cr mice are mutated in the same genetic locus 
as another LPS-resistant  mouse strain, C3H/HeJ. The LPS 
resistance of C3H/HeJ mice has been studied in the past by 
several workers and found to be the result of a mutation of 
the LPS gene locus on chromosome 4 (4-6).  The product 
of this locus has not been identified yet. We have shown that 
Cr mice exhibit a second defect.  They differ from Sn and 
C3H/HeJ mice by their inability to exhibit an IFN-3' re- 
sponse after infection with Salmonella typhimurium,  Plasmo- 
dium chabaudi chabaudi,  or treatment with killed Propionibac- 
terium acnes (3, 7). The impaired production of IFN-3' in treated 
Cr mice was accompanied by the absence of development of 
sensitization toward the lethal effects of bacterial endotoxin 
(LPS). In Sn and C3H/HeJ mice, sensitization parallels the 
production of IFN-3' after treatment with microorganisms. 
This observation led finally to the identification of IFN-y 
1 Abbreviations used in this paper: Cr, C57BL/10ScCr;  ds, double-stranded; 
Sn, C57BL/10ScSn. 
as a mediator of the LPS hypersensitivity induced by infec- 
tion (7).  It seems therefore that the production of IFN-3, 
in the course of infection plays a dual role: inducing a higher 
resistance toward the pathogen itself (for review see reference 
8) and increasing susceptibility toward its toxic products, such 
as LPS. 
In vitro analysis of the impaired production of IFN-3, by 
Cr splenoeytes indicated that the defect may be restricted pri- 
marily to microbial stimuli (3). The IFN-3, response of the 
Cr splenocytes to the T  cell mitogen Con A was present, 
although in comparative studies with three other mouse strains 
it was somewhat lower (3). We felt that a closer analysis of 
the impaired IFN-y production in Cr mice might give more 
insight into the rather complicated mechanism of IFN-'y 
production. As known from previous studies, T and NK ceils 
represent the main source of IFN-3~ in the animal host (9-13). 
NK cells have been shown to exhibit rapid IFN-'y responses 
to bacteria and their products in vitro and in vivo and require 
the accessory help of macrophages (13-16;  for a review see 
reference 8). 
This study shows that Cr splenocytes  exhibit impaired IFN-'y 
production after stimulation with all gram-negative bacteria 
so far tested. It is shown that IFN-3,-producing cells of Cr 
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unable to provide the required accessory help. Furthermore, 
evidence is presented that macrophage-produced IFN-/5 is an 
important cofactor in the induction of IFN-3, by gram-negative 
bacteria, and this is absent in bacteria-stimulated Cr cultures. 
Materials and Methods 
Animals.  Sn, Cr, and BALB/c mouse strains were obtained from 
the breeding stock of the Max-Planck-Institut fiir Immunbiologie. 
6-8 wk-old mice of either sex were used as tissue  donors in all 
experiments. 
Bacteria.  Proteus  mirabilis, Pseudomonas  aeruginosa, Escberichia coli 
JS, and S. typhimurium (C5) were obtained from overnight cultures. 
They were washed twice with PBS, pH 7.2, and killed by heating 
in PBS at  100~  for 30 min.  All heat-kiUed bacteria were cen- 
trifuged, washed twice with distilled  water, and lyophilized. 
Antibodies.  Two hybridoma cell lines  producing rat mAb to 
mouse IFN-y were kindly donated by G. L. Spitalny  (R4-6A2; 
Trudeau  Institute,  Saranac  Lake,  NY)  (17) and  S.  Landolfo 
(AN18.17.24;  Institute  of Microbiology,  University of Torino, 
Torino, Italy) (18), respectively, mAbs were isolated from the hy- 
bridoma supernatants as described previously (7). Anti-CD3 mAb 
(19) was kindly provided by I.  Miiller (University of Lausanne, 
Lausanne, Switzerland). Polyclonal anti-IFN-B was prepared in a 
rabbit immunized four times with increasing amounts of a recom- 
binant murine IFN-B (10-50/xg) in IFA. The antiserum obtained 
was highly active (up to a dilution of 1:10,000) in immunoblot 
analysis with murine rIFN-~ as antigen. The preimmune serum 
of the same rabbit served for control experiments. Monoclonal anti- 
IFN-I~ (rat IgG1; protein concentration 10 mg/ml) was purchased 
from Yamasa Shoyu (Tokyo, Japan).  Monoclonal anti-IFN-c~ (rat 
IgG1;  200 #g/m1) was purchased from GIBCO BRL (Gaithers- 
burg, MD). Rat IgG (10 mg/ml), purified from normal rat serum 
as described  earlier  (7),  was  used in control experiments. 
Chemicals.  Recombinant routine IFN-'y was kindly provided by 
G. R. Adolph (Bender & Co., Vienna, Austria).  Recombinant mu- 
rine IFN-~ was a kind gift from Dr. Moryama (Toray Industries 
Inc., Tokyo, Japan).  Recombinant murine IFN-c~ was purchased 
from GIBCO BRL. Con A was purchased from Pharmacia (Frei- 
burg, Germany). Double-stranded (ds) RNA [Poly(I) .Poly(C)] was 
purchased from Boehringer Mannheim (Mannheim, Germany). LPS 
ofSalraonella abortus  equi was prepared as described previously (20). 
Cells.  Macrophages were derived from bone marrow precursor 
cells flushed from mouse femora as previously described (21). Spleen 
cell suspensions  were prepared at a concentration of 107 ceUs/ml 
of a high-glucose formulation of DME as previously described (22). 
The cells were cultured in plastic 96-well plates (Nunc, Koskilde, 
Denmark) in a volume of 200/~1, or in 6-well plates (Costar, Cam- 
bridge, MA) in a volume of 3 ml in a humidified atmosphere con- 
taining 8% COs at 37~  for 24 h. For determination of IFN-% 
culture supernatants were stored in aliquots at -80~  Macrophage- 
depleted spleen cells were prepared as follows:  Spleen cells were 
incubated at a concentration of 10  s cells/ml in DME containing 
carbonyl-iron (reduced pentacarbonyl iron; Sigma,  Deisenhofen, 
Germany) at a concentration of 200 mg/10  s cells for 1 h at 37~ 
in a humidified atmosphere containing 8% COs. Phagocytes con- 
taining carbonyl-iron were removed from the spleen cell suspen- 
sions along with free carbonyl-iron by a magnet. The remaining 
cells were suspended  in DME at a concentration of 107 ceUs/ml. 
FACS  |  analysis (Becton Dickinson & Co., Mountain View, CA) 
of spleen ceUs before and after this treatment indicated that the 
number of Mac-1 + (23) cells (macrophages)  decreased from 5 to 
<0.2%  of the total cell  population and that  the percentage of 
6B2 + (24) cells (B cells) increased  from 59 to 67%. There were 
no significant  changes  in the concentrations of Thy-1 + (25) and 
NKI.1 § (26) cells (T and NK cells). The mAbs to Mac-l, 6B2, 
and Tby-1 were kindly provided by R. Carsetti (Max-Planck-Institut 
flir Immunbiologie) and to NKI.1 by S. Vogel (Uniformed Ser- 
vices University of the Health Sciences, Bethesda,  MD). 
Measurement oflNF-  7.  Concentrations of IFN-)' in culture su- 
pernatants were determined by a previously described spedfic ELISA 
technique (27). All IFN-3, values represent the average of four iden- 
tical cultures; the SD was always <20%. The detection limit was 
1-5 U  IFN-q,/ml. 
Northern Blot Analysis.  Total RNA was isolated by a guanidi- 
nium isothiocyanate-phenol-chloroform/isoamylalcohol  procedure 
(28). Briefly, 3  x  107 cells were suspended  in 0.5 ml of solution 
D, which contained 4 M guanidinium isothiocyanate,  25 mM so- 
dium citrate (pH 7), 0.5% sarcosyl, and 0.1 M 2-ME. Subsequently, 
50/~1 of 2 M  sodium acetate (pH 4), 0.5 ml of water-saturated 
phenol, and 100/zl ofchloroform/isoamylalcohol  (25:1) were added. 
The mixture was incubated on ice for 15 min, and phase separation 
was accomplished by centrifugation at 4~  Total RNA was precipi- 
tated from the aqueous  phase by the addition of one volume of 
isopropanol after chilling to  -20~  The precipitates  were col- 
lected by centrifugation, resuspended  in 0.3 ml of solution D, and 
reprecipitated with 0.3  ml isopropanol. The RNA pellets  were 
washed twice with 75% ethanol and resuspended in 10 #1 HzO. 
The RNA concentration was determined by absorbance at 260 nm. 
RNA  samples  (3-5  /~g) were  fractionated on  1%  denaturing 
agarose-formaldehyde gels by use of standard conditions (29). The 
RNAs were transferred to Nytran filters  (Schleicher  & Schuell, 
Dasset,  Germany) by capillary blotting and UV cross-linking to 
the filter. RNAs were hybridized overnight at 42~  with random- 
primed 3sp-labeled cDNA probes.  The IFN-'y probe was a 700- 
bp cDNA fragment (EcoRI/BglII) of mouse IFN-3~ provided by 
D. St(iber (Roth, Basel, Switzerland). IFN-B probe was a 571-bp 
PCR fragment spanning the complete open reading frame for mu- 
rine IFN-3 cloned into the SmaI site of pTz19 (Pharmacia).  The 
conditions for the amplification were 94~  for 40 s, 59~  for 30 s, 
and 72~  for 1 min with 300 ng mouse genomic DNA in a 50 
/~1 reaction volume, 200 #M dNTP, 0.2 U  Super Taq (Stehelin, 
Basel, Switzerland) and 0.5/~M primers (5'-CCAGCCTGGCTT- 
CCATCA-Y and 5'-GGTCTTCAGTTTTGGAAG-3'). After hy- 
bridization, the membranes were washed in 2  x  SSC for 10 min 
at room temperature, followed by 30 min at 42~  in 0.2  x  SSC 
containing 0.1% SDS. Autoradiography was performed by use of 
XOMAT-AR film (Eastman Kodak Co., Rochester, NY) at -80~ 
with an intensifier screen. The intensity of the ribosomal protein 
$12 mRNA (30), detected in different samples on the same blot, 
was used to control RNA loading on the Northern blot. 
Results 
Induction of lFN-'f in Sn and Cr Splenocytes by Con A, Anti- 
CD3 mAbs, and Killed Gram-negative Bacteria.  Stimulation 
with optimal concentrations of either Con A (4/zg) or anti- 
CD3 mAb (10/~g) led to IFN-3, production in both Sn and 
Cr splenocyte cultures.  Con A  induced a somewhat lower 
response in Cr (on average 80 U/ml) than in Sn cultures (120 
U/ml),  whereas  the response to anti-CD3  (115  versus  110 
U/ml)  was  comparable  in  both  cultures.  Treatment  with 
different gram-negative bacteria (S. typhimurium, E. coli JS, 
Proteus mirabilis,  and Pseudomonas aeruginosa),  however, in- 
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Hgure  1.  IFN-'F production by splenocytes  after 
stimulation with different gram-negative bacteria. 
The  IFN-'Ir response  of Sn  and  Cr  splenocytes 
(107/ml) cultured with different amounts (0.02-200 
/~g) of S.  typhimurium,  E. coli JS, P. aeruginosa,  and 
P.  mirabilis was measured as described in Materials 
and Methods. One of five representative  experiments 
is shown. 
duced IFN-3/only in Sn splenocytes, whereas in Cr cultures 
it was virtually ineffective (Fig. 1). Similar results were ob- 
tained with additional strains of Salmonella and E. coli (not 
shown). These results show that Cr mice, while capable of 
producing IFN-? in response to Con A or anti-CD3 mAb, 
exhibit a heavily impaired response to gram-negative bacteria. 
Kinetics of lFN-'y mRNA  Induction and IFN-'y Production 
in Sn and Cr Splenocytes Stimulated by S. tTphimurium.  Fig. 
2 shows cellular IFN-3, mRNA levels and IFN-3' concentra- 
tions in supernatants  of Sn andCr splenocytes at different 
times of S.  tTphimurium treatment. Northern blot analysis 
revealed a low level of IFN-3' mRNA in unstimulated cells 
of  both mouse strains. After stimulation, IFN-3, mRNA and 
IFN-? production increased temporarily in Sn splenocytes 
(maximum values at 8 and 12 h, respectively). In Cr spleno- 
cytes, neither mRNA increase nor IFN-3, production was 
observed. 
Impaired Accessory  Function of Cr Macrophages in the IFN-'y 
Response to Bacteria.  Macrophages play an accessory role in 
the response of IFN-y-producing cells to bacterial stimuli 
(8, 13-15, 31). We therefore investigated  whether macrophages 
are required  in the IFN-? response to S.  typhimurium and, 
if so, whether Cr macrophages are able to provide this func- 
tion. Sn splenocytes  were depleted of  macrophages as described 
in Materials and Methods and their IFN-3, response to a stan- 
dard dose of S. typhimurium (20/~g/2  x  106 cells)  was mea- 
sured. Fig. 3 shows that removal of macrophages abolished 
the ability of splenocytes to produce IFN-3,. Reconstitution 
with new, bone marrow-derived Sn macrophages restored 
the IFN-qr response. The amount of  IFN-"/produced  increased 
with higher numbers of macrophages  added.  The results 
confirm the essential role of macrophages in the IFN-3, re- 
sponse to bacteria. Reconstitution of Sn splenocytes with Cr 
macrophages failed to restore IFN-~ response to S. typhimu- 
rium (Fig. 3), indicating  an impaired accessory function of 
Cr macrophages. 
The defect of Cr macrophages was confirmed in experi- 
Figure 2.  Time course of mRNA expression and secretion of IFN-? 
by splenocytes stimulated with S. typhimurium.  Splenocytes of Sn and Cr 
.mice (3  x  10  ? cells/3 ml) were cultured  for 0, 4, 8,  12,  16, and 24 h 
with S. tTpkimurium  (300/lg).  16-h  stimulation with Con A (30 #g) served 
as positive control.  IFN-? in culture supernatants was determined by an 
ELISA. IFN-? mRNA was determined  as a single band at 0.8 kb pair 
by Northern blot analysis  as described in Materials and Methods. Amounts 
of total RNA applied to the electrophoresis gel for each sample is visual- 
ized by the intensity  of the ethidium bromide-stained  bands (28S and 18S 
ribosomal RNA).  One of two representative experiments is shown. 
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Figure 3.  IFN-y production by macrophage-depleted 
splenocytes  reconstituted with Sn or Cr macrophages and 
stimulated with S. typhirauriura. Macrophage-depleted  Sn 
and Cr splenocytes and macrophages derived from bone 
marrow precursors were obtained as described  in Materials 
and Methods. 2  x  106 macrophage-depleted splenocytes 
were reconstituted  with the indicated numbers of new 
macrophages and cultured for 24 h with S. typhiraurium 
(20/~g)  in a total volume of 200 #1. IFN-  7  in culture 
supernatants was determined by a specific ELISA. One 
of four representative experiments is shown. 
ments in which whole or macrophage-depleted Cr spleno- 
cytes were supplemented with Sn or Cr macrophages and 
stimulated with bacteria.  In such cultures, only addition of 
Sn macrophages enabled IFN-3( response. Addition of Cr mac- 
rophages was without effect (Figs. 3 and 4). Reconstitution 
of Cr splenocytes with macrophages of a nonrelated mouse 
strain (BALB/c) led also to IFN-y production (not shown). 
Soluble Factor(s)  from Stimulated Sn Macrophages  Repair(s) the 
IFN-7 Response of Cr Spleen Cells.  It is known that soluble 
accessory factors are required for the induction of IFN-y (15, 
32, 33). The following experiments indicate that the induc- 
tion of IFN-'~ by gram-negative bacteria is supported by a 
macrophage factor that is not produced by Cr macrophages. 
Sn macrophages (106/ml) were cultured in the presence of 
S. typkimurium (100/~g) for varying periods of time (1-24 h). 
Different  amounts  of  the  resulting  culture  supernatants 
(4-100/~1) were added to Cr spleen cells (2  x  106) together 
with 20/xg of the different bacteria,  and IFN-y was mea- 
sured after 24 h of culture. Addition of the supernatant to 
Cr spleen cells conferred the ability to produce IFN-'y in re- 
sponse to all bacteria tested. The helper activity was first de- 
tected after 4 h of stimulation, reached its maximum at 8-12 h, 
and decreased thereafter (not shown). Fig.  5 illustrates  the 
induction of IFN-3' in Cr splenocyte cultures supplemented 
with different amounts of 8-h supernatant. The macrophage 
supernatant alone, without bacteria,  did not induce IFN-y. 
IFN-3, was also absent  in the controls containing bacteria 
and supernatants from unstimulated Sn macrophages cultured 
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Figure 4.  IFN-3( response of Cr  splenocytes, sup- 
plemented with Sn macrophages, to bacteria. Splenocytes 
and macrophages were prepared as described in Materials 
and Methods. Different numbers ofSn macrophages were 
mixed with Cr splenocytes in the percentages indicated 
(final concentration  107 cells/ml)  and stimulated  with 
different bacteria (100 vg/ml) for 24 h. IFN-~/in culture 
0.0s  0.4  2  10  supernatants was determined by a specific ELISA. One 
Macrophoges  added  (%  of  fatal  cells)  of four representative experiments is shown. 
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Figure 5.  IFN-3~  response of Cr splenocytes, supplemented with a su- 
pernatant orS. t~himurium-stimuhted Sn macrophages, to bacteria. Spleno- 
cytes and macrophages  were prepared as described  in Materials  and Methods. 
Cr splenocytes were supplemented with different amounts of supernatant 
obtained  from  Sn  macrophages  (106/ml) stimulated  for  8  h  with  S. 
typhimurium (100/zg).  IFN-3, production by these splenocytes (107/ml) 
stimulated with different bacteria (100 #g) was determined  as described 
in Materials  and Methods. One of three representative  experiments is shown. 
for different periods of time (4-24 h; not shown in Fig. 5). 
In similar experiments,  supernatants  from S.  typhimurium- 
treated Cr macrophages did not support induction of IFN-3, 
by bacteria. 
Other bacteria investigated (E. coli, P. mirabilis, P. aerugi- 
nosa; 100/~g/106 cells) also induced the accessory factor in 
Sn macrophages. In addition,  LPS (0.1/zg) and dsRNA (10 
#g) were found to be potent inducers. In Cr macrophages, 
all bacteria and LPS were ineffective,  whereas dsRNA induced 
the factor to the same level as in Sn macrophages. Thus, the 
inability of Cr macrophages to produce the factor involved 
in the induction of  IFN-'y may be restricted to certain stimuli, 
such as gram-negative  bacteria and their components. 
The Macrophage  Factor  Required.for IFN-~ Induction and A b- 
sent in Cr Cultures Is IFN-fl.  In searching for the helper factor 
absent in Cr macrophages, we examined the possibility of 
IFN-ot and IFN-B being the relevant factors since these are 
known to be inducible by LPS and dsRNA (34-36).  Other 
macrophage  products known to be involved in the induction 
of  IFN-3~ (14, 15, 32, 33) could be excluded for reasons given 
in Discussion. Monodonal antimurine IFN-ot and IFN-~ and 
a polyclonal anti-IFN-/8 were tested for their ability to sup- 
press  the  helper  activity  present  in  supernatants  from 
S. typhimurium-stimulated  Sn macrophages. The supernatants 
were incubated with antibodies (1-50 #l/ml) for 1 h at room 
temperature. 100 #1 of  the incubation mixture was then added 
to cultures of Cr spleen cells (2  x  106/100/zl)  and stimu- 
lated  with S.  typhimurium  (20/xg).  IFN-3~ measurements 
showed a dose-dependent  inhibition of helper activity (up 
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Figure 6.  Expression oflFN-/3 mRNA ofmacrophages stimuhted with 
S.  t~hiraurium.  Sn and Cr macrophages were prepared as described in 
Materials and Methods. 3  x  106 macrophages/3 ml were stimulated with 
S. typhimurium (300/~g) for the times indicated. Thereafter, total RNA 
was isolated, and IFN-/3 and ribosomal  $12 mRNA were detected by 
Northern blot analysis, as described in Materials and Methods.  One of 
two representative experiments is shown. 
to  85%)  by the monodonal and  polyclonal  anti-IFN-/$, 
whereas monoclonal anti-IFN-ot and the control antibodies 
exhibited no suppressive effect (not shown). 
Total RNA, obtained  at different times of culture from 
S. t~himuriura-stimulated Sn and Cr macrophages, was ana- 
lyzed by Northern blot with an IFN-/%cDNA probe (Fig. 
6).  In unstimulated macrophages  of either strain,  IFN-B 
mRNA was not detectable. In Sn macrophages,  strong in- 
duction of IFN-~ mRNA was observed between 1 and 8 h 
of stimulation. In Cr macrophages, IFN-/~ mRNA was never 
detectable. Induction of IFN-B mRNA in Sn and its com- 
Figure 7.  IFN-3, production by Cr splenocytes supplemented  with 
rIFN-B or rlFN-c~  and stimulated with bacteria. IFN-3, response of spleno- 
cytes (2  x  106/200/zl) supplemented with 1FN-B or IFN-a (10,000 U) 
and cultured with the different bacteria indicated (20 #g) was measured 
as described in Materials and Methods. One of four representative experi- 
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Figure  8.  Inhibition of IFN-'y re- 
sponse to S. typhimurium in Sn spleno- 
cytes by anti-IFN-/3.  IFN-3, produc- 
tion by Sn splenoeytes (2  x  106/200 
/zl) supplemented with the indicated 
amounts of a monoclonal (10 mg pro- 
tein/ml) or polyclonal anti-IFN-~ and 
stimulated  with S. typhimurium was 
measmx*d as described in Materials and 
Methods.  Preimmune rabbit  serum 
and a rat  IgG preparation  served as 
controls.  One of four representative 
experiments  is shown. 
plete absence in Cr macrophages were also seen after stimu- 
lation with LPS (0.1 gtg/106 cells). Stimulation with dsRNA 
(10/~g/lO  6 cells), however, induced a strong IFN-~ message 
in both Sn and Cr macrophages (not shown). 
We then investigated the effect of murine recombinant 
IFN-3 on the defective IFN-y response of Cr splenocytes. 
Addition of IFN-/3 (5-50,000 U/2  x  106 splenocytes) en- 
abled, in a dose-dependent manner, the induction of IFN-y 
by S. typhimurium. Fig.  7 shows that not only IFN-~ but 
also recombinant IFN-ot enabled a high production of IFN-y 
in Cr splenocytes stimulated with different  gram-negative 
bacteria. 
IFN-/~ Antibodies Inhibit Induction of lFN-%  The extent 
to which endogenous IFN-3 is required for the induction 
of IFN-y by gram-negative bacteria was investigated by use 
of antibodies against IFN-~. Both anti-IFN-/~ preparations 
inhibited the IFN-y response of Sn splenocytes to S. typhimu- 
rium in a dose-dependent manner (Fig. 8). With the highest 
amount of anti-IFN-/3  (5/zl/2  x  106 cells), "~60-70% in- 
hibition was achieved. This amount of antibody inhibited 
the induction of IFN-y (up to 80%) by all bacteria used in 
this study (not shown). Neither anti-IFN-ot nor the control 
immunoglobulins  exhibited an inhibitory effect. Thus, in mice, 
IFN-3 is an important cofactor in the induction of IFN-y 
by gram-negative bacteria. 
Discussion 
This present study demonstrates that splenocytes of Cr mice, 
in contrast to splenocytes of closely related Sn mice, exhibit 
defective IFN-y production in response to gram-negative bac- 
teria. This finding is in agreement with our previous results 
showing that IFN-y production in Cr mice infected with 
different microorganisms is impaired (3, 7). Cr mice, how- 
ever, do not possess a general defect in IFN-y response, since 
Cr splenocytes produce high levels of IFN-y after stimula- 
tion with Con A  or anti-CD3. 
The use of macrophage-depleted spleen cells from Sn and 
Cr mice and their reconstitution with macrophages of either 
strain enabled an analysis of the IFN-y defect in Cr mice. 
The absence of the IFN-y response to S. typhimurium from 
macrophage-depleted Sn splenoeytes and its restoration by 
addition of new Sn macrophages confirm the essential role 
of macrophages in the IFN-y response. The inability of Cr 
macrophages to substitute for Sn macrophages shows that 
the former are defective. Consequently, when Cr splenocytes 
were supplemented  with functionally intact Sn macrophages, 
they acquired the ability to produce IFN-y after stimulation 
with all bacteria  tested.  This shows that in Cr mice, only 
the macrophages are defective, and the IFN-3,-producing cells 
themselves  are normal. 
Macrophages are believed to interact directly with IFN- 
v-producing cells (31) and are known to secrete factors es- 
sential for IFN-y induction (14, 32, 33). We show here that 
the defect of Cr macrophages is related to the absence of at 
least one soluble factor. Factors involved in IFN-y induction 
and that may derive from macrophages are IL-1,  TNF-ot, 
and IL-12 (14, 15, 32, 33). Cr macrophages and splenocytes 
produce TNF-ot and IL-1 (37; Freudenberg, M. A., and H. 
Loppnow, unpublished data) in response to bacteria. Regarding 
IL-12, we have detected induction of mP,.NA for both IL-12 
subunits (38), preceding that of IFN-y mRNA, in bacteria- 
stimulated Sn and Cr splenocytes (Yaegashi, Y., and M. A. 
Freudenberg, unpublished data).  These data indicated that 
a macrophage product, not yet recognized as a cofactor of 
IFN-y induction, is missing in Cr mice. The missing factor 
could be identified here as IFN-3 for the following reasons. 
Expression of IFN-B mRNA in Sn macrophages correlated 
with the appearance of the factor  in macrophage superna- 
tants. Furthermore, exogenous IFN-3 restored IFN-'y produc- 
tion in Cr splenocytes. Finally, IFN-/3 antibodies inhibited 
the helper effect of macrophage supernatants as well as the 
induction of IFN-y in Sn splenocytes. 
IFN-3 shares the same cellular receptors with IFN-ot, which 
explains why both cytokines exhibit similar biological activities 
(35). In this study, both recombinant IFNs (or and 3) repaired 
the defect of Cr splenocytes. Thus both types of IFN may, 
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However, only anti-IFN-/$ and not anti-IFN-c~ inhibited the 
helper activity of macrophage  supernatants and the induc- 
tion of IFN-"/in stimulated Sn splenocytes.  These data sug- 
gest that, in mice, bacteria induce predominantly IFN-B, as 
already shown for LPS (36). 
The IFN-B defect of Cr mice, however,  is not a general 
one since Cr macrophages are capable of producing IFN-~/ 
when stimulated with dsKNA. The reason why gram-negative 
bacteria do not induce IFN-B in Cr macrophages is not known. 
The most obvious explanation would be that LPS is the only 
IFN-~/-inducing bacterial component and consequently cannot 
act in LPS-resistant  Cr mice. In this case, the inability of Cr 
mice to produce IFN-B and subsequently IFN-y would be 
directly related to their LPS nonresponsiveness. Gram-negative 
bacteria, however,  have been shown to induce a number of 
macrophage cytokines in Cr mice due to other non-LPS com- 
ponents that they contain. Thus, production of TNF-ot (37), 
IL-1 and IL-6 (Loppnow, H., and M. A. Freudenberg, un- 
published data) and GM-CSF (Kumazawa, Y., R. Gerle, and 
M. A.  Freudenberg, unpublished data) were detected  after 
stimulation with S. typhimurium and other gram-negative  bac- 
teria in Cr and C3H/HeJ mice, despite their LPS nonrespon- 
siveness. These components, although obviously incapable 
of inducing IFN-~ in Cr mice, may well do so in other mouse 
strains,  including C3H/HeJ. This would explain the high 
levels of IFN-3' found in C3H/HeJ mice after stimulation 
with S.  typhimurium  (3).  Further experiments are required 
to understand the defect of Cr mice and the complex mecha- 
nisms involved in IFN-v induction. 
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